CoVP COMMUNICATIONS
Updated CDC Guidance for Use of Bivalent mRNA COVID-19 Vaccines April 24, 2023
The purpose of this communication is to inform CoVP providers that last week the U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) for Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals. Additionally, the Advisory Committee on Immunization Practices (ACIP) met to discuss clinical considerations.
-
April 4, 2023
-
March 13, 2023
Communications
- Update Winter Storm Warning March 13, 2023
- CT WiZ Confidentiality Agreement Renewal February 3, 2023
- Winter Storm Warning and Reminder to Safeguard Your Vaccine Against Power Outages December 22, 2022
- New Under 5-6 Pediatric Bivalent Booster Coming Soon Pre-Order Your Vaccine Now November 30, 2022
- Moderna Shelf Life Extension November 8, 2022
- CDC Recommends Updated Bivalent Booster October 12, 2022
- Moderna Bivalent Booster Available to Order September 22, 2022
- CDC Recommends New Bivalent Booster September 2, 2022
- Pre-Order (wave 2) the New Bivalent Booster Now, August 25, 2022
- Novavax Now Available for Order: July 26, 2022
- COVID-19 Vaccine Provider Update Call: July 6, 2022
- Moderna Monovalent COVID 19 Vaccine Expiry Stock Out Alert March 2, 2023
- Very Limited Redistribution of COVID19 Vaccine Available January 12, 2023
- CDC Recommends Updated Bivalent Vaccine for Everyone 6 Months and Older December 9, 2022
- New Pfizer Single Dose Vials and COVID-19 Vaccine Updates November 14, 2022
- CDC COVID-19 Vaccine Updates October 24, 2022
- New Pediatric Bivalent Booster Coming Soon September 29, 2022
- Moderna Bivalent Booster Availability September 12 2022
- New Fall Bivalent Booster EUA And Updated Use of Monovalent Boosters August 31, 2022
- New Bivalent Booster Coming Soon August 19, 2022
- Pfizer BLA Novavax USA Fall Booster Updates: July 20, 2022
- View Archived CoVP Communications